Newswise Feature Channel: Clinical Trials

AMR Expands Clinical Research Offerings in the Carolinas with Waccamaw Dermatology Partnership

Alliance for Multispecialty Research (AMR) — Thu, 18 Jul 2024 08:05:11 EST

Alliance for Multispecialty Research (AMR), a leading clinical research site company, and Waccamaw Dermatology, renowned for its comprehensive, specialized dermatological care as one of the largest physician-owned and led dermatology practices in the Carolinas, today announced a strategic partnership that expands access to clinical trials in the Carolinas.

Participate in Study to Reduce Disparate Growth of Alzheimer's Disease in Black Population

Corewell Health — Mon, 15 Jul 2024 20:05:31 EST

Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer's disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition's disparate attack.

Clinical-grade microbiome drug manufacturing facility opens at UChicago

University of Chicago Medical Center — Mon, 15 Jul 2024 14:05:57 EST

The first of its kind at an academic institution, the facility gives experts the capability to put live bacteria into capsules that can be administered safely to patients in clinical trials.

New medication for stress urinary incontinence? Investigational drug shows promise

Wolters Kluwer Health: Lippincott — Thu, 11 Jul 2024 13:30:16 EST

An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology(r), an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

MD Anderson Research Highlights for July 11, 2024

University of Texas MD Anderson Cancer Center — Thu, 11 Jul 2024 12:00:14 EST

The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Call for Papers: Theme Issue: Artificial Intelligence in Oncology

JMIR Publications — Thu, 11 Jul 2024 09:00:24 EST

JMIR Publications invites submissions to a new theme issue titled "Artificial Intelligence in Oncology" in its premier open access journal JMIR Bioinformatics and Biotechnology indexed in PubMed Central and PubMed, SCOPUS, Sherpa/Romeo, DOAJ and EBSCO/EBSCO Essentials.

Mayo Clinic marks medical milestone with world's first known successful total larynx transplant performed in a patient with an active cancer as part of a clinical trial

Mayo Clinic — Tue, 09 Jul 2024 08:05:49 EST

Mayo Clinic announces a groundbreaking achievement in organ transplantation, offering hope to thousands who have lost their ability to speak, swallow and breathe on their own due to diminished function or loss of their larynx. A multidisciplinary team of doctors in Arizona performed the third known total larynx transplant in the U.S.

From 'trial and error' to targeted precision: $17.9M grant accelerates mental health research

Michigan Medicine - University of Michigan — Tue, 09 Jul 2024 05:05:08 EST

A major new grant will fund a study enrolling thousands of people from the time they schedule a mental health appointment, and gather data that could form the basis for precisely targeted treatment in future.

First Patient Receives ACES(tm) Automatic Continuous Effusion Shunt System at UNC School of Medicine for Pleural Effusion

University of North Carolina School of Medicine — Tue, 02 Jul 2024 14:05:34 EST

In collaboration with the company Pleural Dynamics, researchers at the UNC School of Medicine are the first to use a fully implantable automatic effusion shunt with no external catheters or expensive drainage canisters to provide an innovative new option for patients who struggle with chronic fluid collection.

New MSU study finds systematic biases at play in clinical trials

Michigan State University — Tue, 02 Jul 2024 10:05:31 EST

MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.

Cancer Center Clinical Research Capacity and Benchmarking in the Post-Pandemic Era

Association of American Cancer Institutes (AACI) — Mon, 01 Jul 2024 16:05:00 EST

"North American Cancer Center Clinical Research Capacity and Benchmarking in the Post-Pandemic Era" was published July 1 in JCO Oncology Practice, an American Society of Clinical Oncology (ASCO) Journal.

Respiratory Societies Help Bring the World Together for Bronchiectasis

American Thoracic Society (ATS) — Mon, 01 Jul 2024 09:05:11 EST

In support of the third annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is joining the COPD Foundation and several global organizations to raise awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.

Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds

Dana-Farber Cancer Institute — Thu, 27 Jun 2024 16:00:00 EST

* 97% of HER2+, early-stage patients treated with trastuzumab emtansine (T-DM1) were free of cancer recurrence five years after treatment * Prognostic test (HER2DX) shown helpful in identifying patients at greatest risk for recurrence

Advancing regenerative medicine therapies

University of California, Irvine — Wed, 26 Jun 2024 12:05:24 EST

University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility's grand opening in Hewitt Hall's basement on the UC Irvine campus. Although the highly sterile environment remains off-limits for tours, the gala highlighted its importance to the campus, the UC system and the local community.

New Survey from NCCN Finds Cancer Drug Shortage Management Remains a Moving Target, Impacting Clinical Trials

National Comprehensive Cancer Network(r) (NCCN(r)) — Wed, 26 Jun 2024 09:00:00 EST

NCCN shares new data on continued high prevalence for cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.

Researchers report first effective use of immunotherapy for most common subtype of colorectal cancer

Dana-Farber Cancer Institute — Tue, 25 Jun 2024 13:05:23 EST

These clinical trial results point to the first safe and effective use of immunotherapy for patients with microsatellite stable colorectal cancer, the most common subtype of the disease. The encouraging results of this phase I trial have prompted Dana-Farber investigators to move forward with a phase III trial of this immunotherapy combination.

Electroconvulsive therapy or ketamine? Clinical factors affect outcomes

UT Southwestern Medical Center — Tue, 25 Jun 2024 11:05:21 EST

Patients with moderate to severe treatment-resistant depression (TRD) might have better symptom relief from ketamine infusions than from electroconvulsive therapy (ECT), but those with severe TRD could benefit more from ECT early in treatment, an analysis led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, are the first to identify characteristics that distinguish which treatments might benefit TRD patients more.

Study Identifies First Drug Therapy for Sleep Apnea

UC San Diego Health — Fri, 21 Jun 2024 15:45:00 EST

UC San Diego School of Medicine international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea.

Kids from disadvantaged communities may die sooner from cancerous brain tumors

Michigan Medicine - University of Michigan — Thu, 20 Jun 2024 10:30:06 EST

Children with inoperable brain tumors may die sooner if they live in areas with lower average income and education levels, a Michigan Medicine-led study finds. Income and educational attainment, the researchers suggest, may affect the landscape of diagnosis and treatment of brain tumors.

Modifying homes for stroke survivors saves lives, extends independence

Washington University in St. Louis — Wed, 19 Jun 2024 12:05:49 EST

Researchers at Washington University School of Medicine in St. Louis have found that safety interventions - such as walkers, grab bars, ramps and other home modifications - allow many stroke survivors to keep living independently in their homes and may reduce their risk of death.